Eamonn P. Hobbs

Eamonn P. Hobbs, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Angiodynamics Inc, Orasure Technologies Inc and Antares Pharma, Inc. We count 85 filings; the first trade dates from 30 October 2004 and the latest from 16 May 2022.

Both buying and selling appear: 6 purchases worth €320k, against 22 sales worth €4.5M. On balance, insiders were net sellers of €4.2M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 26 share grants and 30 option exercises.

Half of the purchases are above €17k and half below.

On 18 May 2022 came the latest disclosure, a share grant for €101k in Orasure Technologies Inc. The most recent open-market purchase was published on 12 September 2014, 4,440 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.